These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14497974)

  • 1. Familial hyperprolinemia, cerebral dysfunction and renal anomalies occurring in a family with hereditary nephropathy and deafness.
    Schafer IA; Scriver CR; Efron ML
    N Engl J Med; 1962 Jul; 267():51-60. PubMed ID: 14497974
    [No Abstract]   [Full Text] [Related]  

  • 2. FAMILIAL HYPERPROLINEMIA. REPORT OF A SECOND CASE, ASSOCIATED WITH CONGENITAL RENAL MALFORMATIONS, HEREDITARY HEMATURIA AND MILD MENTAL RETARDATION, WITH DEMONSTRATION OF AN ENZYME DEFECT.
    EFRON ML
    N Engl J Med; 1965 Jun; 272():1243-54. PubMed ID: 14290545
    [No Abstract]   [Full Text] [Related]  

  • 3. RENAL TUBULAR TRANSPORT OF PROLINE, HYDROXYPROLINE, AND GLYCINE IN HEALTH AND IN FAMILIAL HYPERPROLINEMIA.
    SCRIVER CR; EFRON ML; SCHAFER IA
    J Clin Invest; 1964 Mar; 43(3):374-85. PubMed ID: 14135488
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and clinical features of hereditary hyperprolinemia.
    Mitsubuchi H; Nakamura K; Matsumoto S; Endo F
    Pediatr Int; 2014 Aug; 56(4):492-6. PubMed ID: 24931297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYPERPROLINAEMIA AND HEREDITARY NEPHRITIS.
    KOPELMAN H; ASATOOR AM; MILNE MD
    Lancet; 1964 Nov; 2(7369):1075-9. PubMed ID: 14207890
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Δ-1-pyrroline-5-carboxylate derived biomarkers for hyperprolinemia type II.
    Merx J; van Outersterp RE; Engelke UFH; Hendriks V; Wevers RA; Huigen MCDG; Waterval HWAH; Körver-Keularts IMLW; Mecinović J; Rutjes FPJT; Oomens J; Coene KLM; Martens J; Boltje TJ
    Commun Biol; 2022 Sep; 5(1):997. PubMed ID: 36131087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inborn errors of proline metabolism.
    Mitsubuchi H; Nakamura K; Matsumoto S; Endo F
    J Nutr; 2008 Oct; 138(10):2016S-2020S. PubMed ID: 18806117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia.
    van de Ven S; Gardeitchik T; Kouwenberg D; Kluijtmans L; Wevers R; Morava E
    J Inherit Metab Dis; 2014 May; 37(3):383-90. PubMed ID: 24173411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term neuropsychiatric follow-up in hyperprolinemia type I.
    Di Rosa G; Nicotera AG; Lenzo P; Spanò M; Tortorella G
    Psychiatr Genet; 2014 Aug; 24(4):172-5. PubMed ID: 24842239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.
    Clelland JD; Read LL; Drouet V; Kaon A; Kelly A; Duff KE; Nadrich RH; Rajparia A; Clelland CL
    Schizophr Res; 2014 Jun; 156(1):15-22. PubMed ID: 24787057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolinemia induces DNA, protein and lipid damage in blood of rats: antioxidant protection.
    Ferreira AG; Scherer EB; da Cunha AA; Manfredini V; Biancini GB; Vanzin CS; Vargas CR; Wyse AT
    Int J Biochem Cell Biol; 2014 Sep; 54():20-5. PubMed ID: 24980685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that hyperprolinemia alters glutamatergic homeostasis in rat brain: neuroprotector effect of guanosine.
    Ferreira AG; da Cunha AA; Scherer EB; Machado FR; da Cunha MJ; Braga A; Mussulini BH; Moreira JD; Wofchuk S; Souza DO; Wyse AT
    Neurochem Res; 2012 Jan; 37(1):205-13. PubMed ID: 21935728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hyperprolinemia without mental retardation and hereditary nephropathy.
    Mollica F; Pavone L; Antener I
    Monogr Hum Genet; 1972; 6():144-5. PubMed ID: 4663888
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome.
    Clelland CL; Read LL; Baraldi AN; Bart CP; Pappas CA; Panek LJ; Nadrich RH; Clelland JD
    Schizophr Res; 2011 Sep; 131(1-3):139-45. PubMed ID: 21645996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline.
    Valle D; Goodman SI; Harris SC; Phang JM
    J Clin Invest; 1979 Nov; 64(5):1365-70. PubMed ID: 500817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental hyperprolinemia induces mild oxidative stress, metabolic changes, and tissue adaptation in rat liver.
    Ferreira AG; da Cunha AA; Machado FR; Pederzolli CD; Dalazen GR; de Assis AM; Lamers ML; dos Santos MF; Dutra-Filho CS; Wyse AT
    J Cell Biochem; 2012 Jan; 113(1):174-83. PubMed ID: 21882227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drosophila delta-1-pyrroline-5-carboxylate dehydrogenase (P5CDh) is required for proline breakdown and mitochondrial integrity-Establishing a fly model for human type II hyperprolinemia.
    He F; DiMario PJ
    Mitochondrion; 2011 May; 11(3):397-404. PubMed ID: 21168532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Familial hyperprolinemia with nephropathy].
    Ortuño Mirete J; Guardiola Vicente JM; Botella García J
    Rev Clin Esp; 1970 Jul; 118(2):141-50. PubMed ID: 5486371
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial nephropathy and deafness: first observation of a family and close relatives in Switzerland.
    Dubach UC; Minder FC; Antener I
    Helv Med Acta; 1966 Apr; 33(1):36-43. PubMed ID: 5927986
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of PRODH mutations in Korean neonates with type I hyperprolinemia.
    Jang MA; Kim BC; Ki CS; Lee SY; Kim JW; Choi TY; Lee DH; Song J; Lee YW; Park HD
    Ann Clin Lab Sci; 2013; 43(1):31-6. PubMed ID: 23462603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.